BibTex format
@inproceedings{Routy:2022:10.1136/jitc-2022-sitc2022.0614,
author = {Routy, B and Lenehan, J and Daisley, B and Messaoudene, M and Al, K and Richard, C and Miller, W and Jamal, R and Ernst, S and Logan, D and Belanger, K and Martinez-Gili, L and Mullish, B and Takis, P and Samayoa, CH and Ninkov, M and Parvathy, SN and Lambert, C and Elkrief, A and Lapointe, R and Haeryfar, M and Burton, J and Silverman, M and Maleki, S},
doi = {10.1136/jitc-2022-sitc2022.0614},
pages = {A646--A646},
publisher = {BMJ Publishing Group Ltd},
title = {614Microbiome modification with fecal microbiota transplant from healthy donors before anti-PD1 therapy reduces primary resistance to immunotherapy in advanced and metastatic melanoma patients},
url = {http://dx.doi.org/10.1136/jitc-2022-sitc2022.0614},
year = {2022}
}
RIS format (EndNote, RefMan)
TY - CPAPER
AU - Routy,B
AU - Lenehan,J
AU - Daisley,B
AU - Messaoudene,M
AU - Al,K
AU - Richard,C
AU - Miller,W
AU - Jamal,R
AU - Ernst,S
AU - Logan,D
AU - Belanger,K
AU - Martinez-Gili,L
AU - Mullish,B
AU - Takis,P
AU - Samayoa,CH
AU - Ninkov,M
AU - Parvathy,SN
AU - Lambert,C
AU - Elkrief,A
AU - Lapointe,R
AU - Haeryfar,M
AU - Burton,J
AU - Silverman,M
AU - Maleki,S
DO - 10.1136/jitc-2022-sitc2022.0614
EP - 646
PB - BMJ Publishing Group Ltd
PY - 2022///
SP - 646
TI - 614Microbiome modification with fecal microbiota transplant from healthy donors before anti-PD1 therapy reduces primary resistance to immunotherapy in advanced and metastatic melanoma patients
UR - http://dx.doi.org/10.1136/jitc-2022-sitc2022.0614
UR - http://hdl.handle.net/10044/1/103665
ER -